Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis.
Hondelink LM, Schrader AMR, Asri Aghmuni G, Solleveld-Westerink N, Cleton-Jansen AM, van Egmond D, Boot A, Ouahoud S, Khalifa MN, Wai Lam S, Morreau H, Bovee JVMG, van Wezel T, Cohen D. Hondelink LM, et al. Among authors: schrader amr. Eur J Cancer. 2022 Sep;173:229-237. doi: 10.1016/j.ejca.2022.06.030. Epub 2022 Aug 4. Eur J Cancer. 2022. PMID: 35933886 Free article.
High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.
Schrader AMR, Jansen PM, Willemze R, Vermeer MH, Cleton-Jansen AM, Somers SF, Veelken H, van Eijk R, Kraan W, Kersten MJ, van den Brand M, Stevens WBC, de Jong D, Abdul Hamid M, Tanis BC, Posthuma EFM, Nijland M, Diepstra A, Pals ST, Cleven AHG, Vermaat JSP. Schrader AMR, et al. Blood. 2018 May 3;131(18):2086-2089. doi: 10.1182/blood-2017-12-822817. Epub 2018 Mar 7. Blood. 2018. PMID: 29514783 Free article. No abstract available.
MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis.
Vermaat JS, Somers SF, de Wreede LC, Kraan W, de Groen RAL, Schrader AMR, Kerver ED, Scheepstra CG, Berenschot H, Deenik W, Wegman J, Broers R, de Boer JD, Nijland M, van Wezel T, Veelken H, Spaargaren M, Cleven AH, Kersten MJ, Pals ST. Vermaat JS, et al. Among authors: schrader amr. Haematologica. 2020 Jan 31;105(2):424-434. doi: 10.3324/haematol.2018.214122. Print 2020. Haematologica. 2020. PMID: 31123031 Free PMC article.
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas.
Schrader AMR, de Groen RAL, Willemze R, Jansen PM, Quint KD, van Wezel T, van Eijk R, Ruano D, Tensen CP, Hauben E, Woei-A-Jin FJSH, Busschots AM, van den Berg A, Diepstra A, Vermeer MH, Vermaat JSP. Schrader AMR, et al. Virchows Arch. 2022 Mar;480(3):667-675. doi: 10.1007/s00428-021-03265-5. Epub 2022 Jan 14. Virchows Arch. 2022. PMID: 35028710 Free PMC article.
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring.
Schrader AMR, de Groen RAL, Willemze R, Jansen PM, Quint KD, Cleven AHG, van Wezel T, van Eijk R, Ruano D, Veelken JHH, Tensen CP, Neelis KJ, Daniels LA, Hauben E, Woei-A-Jin FJSHS, Busschots AMA, Vermeer MH, Vermaat JSP. Schrader AMR, et al. Cancers (Basel). 2022 Oct 20;14(20):5152. doi: 10.3390/cancers14205152. Cancers (Basel). 2022. PMID: 36291936 Free PMC article.
TOX expression in cutaneous B-cell lymphomas.
Schrader AM, Jansen PM, Willemze R. Schrader AM, et al. Arch Dermatol Res. 2016 Aug;308(6):423-7. doi: 10.1007/s00403-016-1654-7. Epub 2016 May 14. Arch Dermatol Res. 2016. PMID: 27180090 Free PMC article.
20 results